Skip to main content
Equibles

NIVF · NewGenIvf Group Ltd

Track NIVF — free

Use NIVF with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NIVF.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.20 -0.05 (-18.89%)
Rebalance outlook locked
Market Cap
$1.71M
Shares
6.82M
Volume · Oct 21 11.18M Avg daily vol (7 sessions) 35.12M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.25 Open$0.26 Day$0.25–0.28 52W close$0.20–2,825.28 Avg vol 30d21.1M Short int18K · 0.3% float · 1.0d Short vol45% DataApr 2024–Oct 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
-13.0%
Year over year
Operating margin
-226.9%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+2,731,009.2%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
0.3%
Latest settlement · 1.0 days to cover
View all 122 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Neutral Momentum Very Weak Sentiment Neutral Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 17.3 · elevated Equity put/call 0.56
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg −100%
below
Price vs 50-day avg −93%
below
RSI (14) 23
oversold
MACD trend Positive
52-week position 0%
near low
Volume (OBV) Bullish div.
accumulating
Momentum
relative strength
Very Weak
1-month return −92%
trailing
6-month return −100%
trailing
YTD return −100%
this year
Relative strength −108%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $3 › 200d $60 — 200d above 50d
Institutional flow Flat
0% holders QoQ · +3 funds added
Insider flow Accumulating
Net +$2.5M over 90 days · 0% sells
Short interest Rising
0.26% of float · ▲ +324.1% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
17 holders — mid 2-yr range
Squeeze score 49
elevated · 0–100
Fundamentals
Weak
Revenue growth −13%
Y/Y
Gross margin 20%
contracting
EPS growth +100%
Y/Y
Free cash flow $-11.1M
Quant / Vol
risk profile
Very High
Volatility 233%
annualized · 1-yr
Max drawdown −100%
past year
ATR 138.5%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
3 · 2 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−100% Bearish
Price vs 50-day avg
−93% Bearish
RSI (14)
23 Neutral
MACD trend
Positive Bullish
52-week position
0% Bearish
Volume (OBV)
Bullish div. Bullish
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $3 › 200d $60 — 200d above 50d
Institutional flow Flat
0% holders QoQ · +3 funds added
Insider flow Accumulating
Net +$2.5M over 90 days · 0% sells
Short interest Rising
0.26% of float · ▲ +324.1% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
17 holders — mid 2-yr range
Price context
position in its 52-week range
Range low $0 Now $0 · 0% Range high $2,825
vs 200-day avg -100% vs 50-day avg -93%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Care Facilities — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
NIVF
NewGenIvf Group Ltd
this stock
$1.71M — -13.0% — 0.3%
HCA
HCA Healthcare, Inc.
 $103.32B -0.2% +7.1% 15.6 2.2%
FSNUY
Fresenius SE & Co. KGaA
 $28.30B -12.4% — — 0.0%
THC
Tenet Healthcare Corp
 $21.93B +37.0% +0.9% 10.3 2.3%
EHC
Encompass Health Corp
 $12.00B +14.6% +10.5% 19.8 3.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
17
% held
22.6%
Net QoQ
-652.1K sh
Top holder
Clear Street Group Inc.
Held Float
View
Short & Settlement
Short Interest Rising
Shares short
17.5K
Days to cover
1.0d
Change
+13.4K sh
View
Short Volume
Short vol %
45%
As of
Oct 20, 2026
Short Total
View
Fails to Deliver
FTD shares
554.2K
Value
$38.8K
As of
Sep 30, 2026
View
Off-Exchange
Off-exchange %
100.0%
Week of
Sep 14, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net buying
Net (90d)
+$2.5M
Buyers / Sellers
1 / 0
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$4.7M
Net income (FY)
$9.9M
EPS diluted
$109.44
View
Filings
SEC Filings
Latest
6-K
Filed
Oct 21, 2026
This year
26

NewGenIvf Group Limited’s reverse stock split becomes effective at 12:01 a.m. (ET) on October 23, 2026, combining every eight (8) shares into one; its Class A Ordinary Shares will begin split-adjusted Nasdaq trading under “NIVF.”

View

Performance

5D 20D 120D MTD YTD
NIVF +27.9% -92.3% -99.6% -62.8% -99.9%
SPY -1.2% -0.6% +8.1% +0.8% +12.8%
vs SPY +29.0% -91.8% -107.7% -63.7% -112.7%
Key facts CIK 1981662 CUSIP G0544E154 Visit website Investor relations